ReachMD
Be part of the knowledge.™Episodes 1-15 of 82
Addressing Issues of CV Mortality in Clinical Trials with IV Iron: Are We Still Getting a Medical Benefit?
CME/CEAddressing Issues of CV Mortality in Clinical Trials with IV Iron: Are We Still Getting a Medical Benefit?
Hyperkalemia in CKD and HFrEF…What Am I Missing?
CME/CEHyperkalemia in CKD and HFrEF…What Am I Missing?
The CKD Patient: Thinking Beyond the Numbers and Dialysis
CME/CEThe CKD Patient: Thinking Beyond the Numbers and Dialysis
Clinical Implications of the Evidence from IV Iron Trials in Heart Failure
CME/CEClinical Implications of the Evidence from IV Iron Trials in Heart Failure
Incorporating Targeted Therapies in Treatment Planning for AAV
CME/CEIncorporating Targeted Therapies in Treatment Planning for AAV
What’s New About Gout? Rheumatology Perspective
MinuteCE®What’s New About Gout? Rheumatology Perspective
Is Managing Gout in the Nephrology Clinic a Challenge?
MinuteCE®Is Managing Gout in the Nephrology Clinic a Challenge?
Center of the Target: Which Patients Are Most Likely to Develop Gout?
MinuteCE®Center of the Target: Which Patients Are Most Likely to Develop Gout?
What Are the Emerging Therapies for Managing Gout?
MinuteCE®What Are the Emerging Therapies for Managing Gout?
Can You Manage Patients With Uncontrolled Gout More Effectively?
MinuteCE®Can You Manage Patients With Uncontrolled Gout More Effectively?
Gout Beyond the Joints: What’s the Hidden Danger?
MinuteCE®Gout Beyond the Joints: What’s the Hidden Danger?
